Antibody Therapy Substitution - Immunomodulation - Monoclonal Immunotherapy /

This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice). The book opens by tracing the transition from IgG subs...

Full description

Saved in:
Bibliographic Details
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing, 2018.
Edition:1st ed. 2018.
Subjects:
Hematology.
Immunology.
Oncology .
ISBN:9783319680385
Online Access: Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation
  • From ImmuneSubstitution to Immunomodulation
  • Manual of Primary and Secondary Immunodeficiencies
  • Manual of Intravenous and Subcutanous IgG Indications in Autoimmune diseases
  • Anti-D IgG Concentrate; a Type of IVIg
  • Mechanisms ofAction/Immunomodulation by IgG Concentrate
  • Immunomodulatory Drugs and Monoclonal Antibodies
  • Use of Intravenous Immunoglobulin in Neurology
  • Use of Intravenous Immunoglobulin in Dermatology
  • Historical Aspects ofPoliclonal IgG Preparations
  • Basics of Immunoglobulins as Effector Molecules and Drugs
  • Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates
  • Current IgG Products and FuturePerspectives
  • Immune Thrombocytopenia: Terminology, Immunomodulation and Platelet Stimulation, ClinicalGuidelines and Management
  • Health-Related Quality of life in patients with Immune Thrombocytopenia
  • ITP in Childhood: Predictors of Disease Duration
  • Immune Functions of Platelets
  • Thrombopoietin Receptor Agonists: Characteristics, Adverse Effects and Indications
  • Registries in Immune Thrombocytopenia: The History of the Intercontinental Cooperative ITP Study Group
  • Monoclonal Antibodies as Immunomodulators and Anti-CancerAgents : Development, Methods, Mechanisms of Actions, Adverse Effects, List of Registered and phase II/IIIMonoclonal Antibodies Targeted to
  • Monoclonal Anti-CD20 (B-Cell) Antibody and Autoimmune Diseases.

Similar Items